PriceTargets.com logo

Coloplast A/S - CLPBF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$121.52 As of 03/21/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for CLPBF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Coloplast A/S Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLPBF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLPBF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Coloplast A/S in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $121.52.

This chart shows the closing price for CLPBF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Coloplast A/S. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
6/25/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
9/23/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
12/22/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
2/20/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/22/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/17/2022Berenberg BankInitiated CoverageHold
3/1/2022BarclaysDowngradeEqual Weight ➝ Underweight
5/7/2020JPMorgan Chase & Co.Reiterated RatingNeutral
(Data available from 3/22/2018 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/24/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/23/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/22/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/21/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/20/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/22/2023

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Coloplast A/S logo
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Read More

Today's Range

Now: $121.52
Low: $121.52
High: $121.52

50 Day Range

MA: $117.94
Low: $112.54
High: $125.38

52 Week Range

Now: $121.52
Low: $95.75
High: $159.05

Volume

N/A

Average Volume

212 shs

Market Capitalization

N/A

P/E Ratio

10.64

Dividend Yield

1.54%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Coloplast A/S?

The following Wall Street research analysts have issued stock ratings on Coloplast A/S in the last year:
View the latest analyst ratings for CLPBF.

What is the current price target for Coloplast A/S?

0 Wall Street analysts have set twelve-month price targets for Coloplast A/S in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Coloplast A/S in the next year.
View the latest price targets for CLPBF.

What is the current consensus analyst rating for Coloplast A/S?

Coloplast A/S currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CLPBF.

What other companies compete with Coloplast A/S?

Other companies that are similar to Coloplast A/S include AddLife AB (publ), Ambu A/S, Ansell, Ansell and BATM Advanced Communications. Learn More about companies similar to Coloplast A/S.

How do I contact Coloplast A/S's investor relations team?

Coloplast A/S's physical mailing address is Holtedam 1-3, Humlebaek, Zealand 3050. The company's listed phone number is (454) 911-1111. The official website for Coloplast A/S is www.coloplast.com. Learn More about contacing Coloplast A/S investor relations.